A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research offers a new and highly promising candidate for enzyme replacement therapy for Fabry disease.